Morphine/naltrexone
Morphine/naltrexone is a combination drug used in the management of chronic pain. It contains morphine, a powerful opioid analgesic, and naltrexone, an opioid antagonist. The purpose of the combination is to provide effective pain relief (from the morphine) while reducing the potential for misuse (through the inclusion of naltrexone).
Composition[edit]
The drug is composed of two active ingredients: morphine sulfate, an opioid analgesic, and naltrexone hydrochloride, an opioid antagonist. Morphine sulfate is responsible for the drug's pain-relieving effects, while naltrexone hydrochloride is intended to deter abuse of the drug.
Mechanism of Action[edit]
Morphine works by binding to mu-opioid receptors in the brain, spinal cord, and other areas of the body. This binding action reduces the perception of pain. Naltrexone, on the other hand, is an opioid antagonist. It works by binding to opioid receptors without activating them, effectively blocking the effects of opioids like morphine. In the case of morphine/naltrexone, the naltrexone is intended to remain sequestered and not released under normal conditions. However, if the drug is tampered with (for example, by crushing or dissolving for injection), the naltrexone is released and can block the effects of the morphine.
Indications[edit]
Morphine/naltrexone is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Side Effects[edit]
Common side effects of morphine/naltrexone include constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, abdominal pain. Serious side effects may include addiction, abuse, and misuse, life-threatening respiratory depression, neonatal opioid withdrawal syndrome, and risks from concomitant use with benzodiazepines or other CNS depressants.
Contraindications[edit]
Morphine/naltrexone is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment, known or suspected gastrointestinal obstruction, and hypersensitivity to morphine or naltrexone.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
